Skip to main content
. 2018 Apr 10;9(27):19006–19013. doi: 10.18632/oncotarget.24873

Figure 1. Glypican-1 (GPC1) expression in pancreatic tissues and circulating exosomes (crExos).

Figure 1

Displayed are the GPC1 protein levels measured by ELISA for (A) Adjacent normal pancreas (NP; n = 13) vs. PDAC (n = 17) tissues and (B) a sub-analysis for matched patient samples (n = 11 vs. 11). (C) GPC1 was measured in crExos from patients with benign pancreatic disease (BPD; total n = 16: intraductal papillary mucinous neoplasms (IPMN), n = 7; chronic pancreatitis (CP), n = 6; serous cystadenoma, SCA, n = 3); and PDAC (n = 27). There was no significant difference between BPD vs. PDAC, or between disease groups using a one-way analysis of variance (ANOVA) and Tukey’s post-hoc honest significant difference (HSD) test. Scatterplots show expression for each sample and the horizontal lines represent the mean expression level and standard deviation.